| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | barasertib | CTRPv2 | pan-cancer | AAC | -0.047 | 0.1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | -0.053 | 0.1 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.049 | 0.1 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | 0.08 | 0.1 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | linifanib | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |